Literature DB >> 24980234

In the (sub)tropics allergic rhinitis and its impact on asthma classification of allergic rhinitis is more useful than perennial-seasonal classification.

Désirée Larenas-Linnemann1, Alexandra Michels, Hanna Dinger, Alfredo Arias-Cruz, Marichuy Ambriz Moreno, Martin Bedolla Barajas, Ruth Cerino Javier, Maria de la Luz Cid Del Prado, Manuel Alejandro Cruz Moreno, Laura Diego Vergara, Roberto García Almaráz, Cecilia Y García-Cobas, Daniel Alberto Garcia Imperial, Rosa Garcia Muñoz, Dante Hernandez Colín, Francisco Javier Linares Zapien, Jorge Agustín Luna Pech, Juan Jose Matta Campos, Norma Martinez Jimenez, Miguel Medina Avalos, Alejandra Medina Hernandez, Albero Monteverde Maldonado, Doris Nereida López, Luis Julian Pizano Nazara, Emanuel Ramirez Sanchez, José Domingo Ramos López, Noel Rodriguez-Pérez, Pablo G Rodriguez Ortiz, Kijawasch Shah-Hosseini, Ralph Mösges.   

Abstract

BACKGROUND: Two different allergic rhinitis (AR) symptom phenotype classifications exist. Treatment recommendations are based on intermittent-persistent (INT-PER) cataloging, but clinical trials still use the former seasonal AR-perennial AR (SAR-PAR) classification. This study was designed to describe how INT-PER, mild-moderate/severe and SAR-PAR of patients seen by allergists are distributed over the different climate zones in a (sub)tropical country and how these phenotypes relate to allergen sensitization patterns.
METHODS: Six climate zones throughout Mexico were determined, based on National Geographic Institute (Instituto Nacional de Estadística y Geografía) data. Subsequent AR patients (2-68 years old) underwent a blinded, standardized skin-prick test and filled out a validated questionnaire phenotyping AR.
RESULTS: Five hundred twenty-nine subjects participated in this study. In the tropical zone with 87% house-dust mite sensitization, INT (80.9%; p < 0.001) and PAR (91%; p = 0.04) were more frequent than in the subtropics. In the central high-pollen areas, there was less moderate/severe AR (65.5%; p < 0.005). Frequency of comorbid asthma showed a clear north-south gradient, from 25% in the dry north to 59% in the tropics (p < 0.005). No differences exist in AR cataloging among patients with different sensitization patterns, with two minor exceptions (more PER in tree sensitized and more PAR in mold positives; p < 0.05).
CONCLUSION: In a (sub)tropical country the SAR-PAR classification seems of limited value and bears poor relation with the INT-PER classification. INT is more frequent in the tropical zone. Because PER has been shown to relate to AR severity, clinical trials should select patients based on INT-PER combined with the severity cataloging because these make for a better treatment guide than SAR-PAR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24980234     DOI: 10.2500/ajra.2014.28.4035

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  4 in total

1.  The pathophysiology of sinonasal conditions and novel therapeutic options.

Authors:  Anju T Peters
Journal:  Am J Rhinol Allergy       Date:  2014 May-Jun       Impact factor: 2.467

Review 2.  Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines.

Authors:  Désirée Larenas-Linnemann; Noel Rodríguez-Pérez; Jorge A Luna-Pech; Mónica Rodríguez-González; María Virginia Blandón-Vijil; Blanca E Del-Río-Navarro; María Del Carmen Costa-Domínguez; Elsy Maureen Navarrete-Rodríguez; Carlos Macouzet-Sánchez; José Antonio Ortega-Martell; César Fireth Pozo-Beltrán; Alan Estrada-Cardona; Alfredo Arias-Cruz; Karen Guadalupe Rodríguez Galván; Herson Brito-Díaz; María Del Rosario Canseco-Raymundo; Enrique Emanuel Castelán-Chávez; Alberto José Escalante-Domínguez; José Luis Gálvez-Romero; Javier Gómez-Vera; Sandra Nora González-Díaz; María Gracia Belinda Guerrero-Núñez; Dante Daniel Hernández-Colín; Alejandra Macías-Weinmann; David Alejandro Mendoza-Hernández; Néstor Alejandro Meneses-Sánchez; María Dolores Mogica-Martínez; Carol Vivian Moncayo-Coello; Juan Manuel Montiel-Herrera; Patricia María O'Farril-Romanillos; Ernesto Onuma-Takane; Margarita Ortega-Cisneros; Lorena Rangel-Garza; Héctor Stone-Aguilar; Carlos Torres-Lozano; Edna Venegas-Montoya; Guillermo Wakida-Kusunoki; Armando Partida-Gaytán; Aída Inés López-García; Ana Paola Macías-Robles; María de Jesús Ambriz-Moreno; Amyra Ali Azamar-Jácome; Claudia Yusdivia Beltrán-De Paz; Chrystopherson Caballero-López; Juan Carlos Fernández de Córdova-Aguirre; José Roberto Fernández-Soto; José Santos Lozano-Sáenz; José Joel Oyoqui-Flores; Roberto Efrain Osorio-Escamilla; Fernando Ramírez-Jiménez; Daniela Rivero-Yeverino; Eric Martínez Infante; Miguel Alejandro Medina-Ávalos
Journal:  World Allergy Organ J       Date:  2020-08-21       Impact factor: 4.084

3.  Allergen sensitization linked to climate and age, not to intermittent-persistent rhinitis in a cross-sectional cohort study in the (sub)tropics.

Authors:  Désirée Larenas-Linnemann; Alexandra Michels; Hanna Dinger; Kijawasch Shah-Hosseini; Ralph Mösges; Alfredo Arias-Cruz; Marichuy Ambriz-Moreno; Martín Bedolla Barajas; Ruth Cerino Javier; María de la Luz Cid Del Prado; Manuel Alejandro Cruz Moreno; Roberto García Almaráz; Cecilia Y García-Cobas; Daniel A Garcia Imperial; Rosa Garcia Muñoz; Dante Hernández-Colín; Francisco J Linares-Zapien; Jorge A Luna-Pech; Juan J Matta-Campos; Norma Martinez Jiménez; Miguel A Medina-Ávalos; Alejandra Medina Hernández; Alberto Monteverde Maldonado; Doris N López; Luis J Pizano Nazara; Emmanuel Ramirez Sanchez; José D Ramos-López; Noel Rodríguez-Pérez; Pablo G Rodríguez-Ortiz
Journal:  Clin Transl Allergy       Date:  2014-06-04       Impact factor: 5.871

Review 4.  How does the efficacy and safety of Oralair(®) compare to other products on the market?

Authors:  Désirée Larenas-Linnemann
Journal:  Ther Clin Risk Manag       Date:  2016-05-27       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.